Vitamin B17 (Laetrile/Amygdalin)
Laetrile is not a vitamin and does not treat cancer. Every controlled evaluation, including a Cochrane review and a large NCI-sponsored clinical trial, found no anticancer benefit and documented cyanide toxicity — including deaths. Do not take it.
What the science says
- Treats or cures cancer Limited evidence
A Cochrane systematic review found no randomized controlled trial showing any benefit of laetrile or amygdalin in cancer, and concluded the risk-benefit balance is unambiguously unfavorable. In the NCI-sponsored clinical trial of 178 patients treated with amygdalin plus a metabolic therapy regimen, no substantive tumor response was seen, disease progressed in essentially all patients within months, and several developed blood cyanide levels approaching the lethal range.
- B17 is a vitamin whose deficiency causes cancer Limited evidence
Amygdalin is a plant cyanogenic glycoside found in apricot and bitter almond kernels. It has no known human requirement, no deficiency syndrome, and no vitamin function. The 'vitamin B17' name was coined promotionally in the 1950s and has never been recognized by any nutrition authority.
- Selectively kills cancer cells because tumors lack rhodanese Limited evidence
The proposed mechanism — that beta-glucosidase in tumors releases cyanide while healthy tissue detoxifies it — does not hold up: human tumors do not reliably express more beta-glucosidase, and the enzyme most responsible for releasing cyanide from amygdalin is gut bacterial, which is why oral dosing is far more toxic than intravenous. That detail explains the poisonings rather than any selectivity.
Dosage & safety
Scientific references
Where to buy
View on iHerbReferral link — this site may earn a commission on purchases.
Related in General health
- Vitamin D3 Strong evidence
- Omega-3 (EPA/DHA) Moderate evidence
- Vitamin B12 Strong evidence
- Multivitamin Limited evidence
- Iron Strong evidence
- Iodine Moderate evidence